Grants and Contributions:
Title:
Japan MNE-Development of a novel product optimizing cell production steps and quality for regenerative medicine applications
Agreement Number:
1011338
Agreement Value:
$75,000.00
Agreement Date:
Sep 18, 2023 - Jul 31, 2024
Description:
The project will combine the technologies of the Firm and its Japanese partner to develop a new product improving cell production steps and quality of cells for regenerative medicine applications. Working in close collaboration with the partner, the Firm will proceed with the experimental demonstration of an optimal combination product, select the go-to-market strategy and advance agreements for its commercial implementation.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Montreal, Quebec, CA H4S 1Z9
Reference Number:
172-2023-2024-Q3-1011338
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
775533284
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 96 days. The total amended value is 75,000 dollars.
Amendment Date
Dec 15, 2023
Recipient's Legal Name:
Targa Biomedical Inc
Federal Riding Name:
Saint-Laurent
Federal Riding Number:
24068
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: